Efficacy of BRAF Inhibitors in Asian Metastatic Melanoma Patients: Potential Implications of Genomic Sequencing in BRAF-Mutated Melanoma()()

BACKGROUND: The BRAF inhibitors vemurafenib and dabrafenib are currently the standard treatment for metastatic melanoma with BRAF V600 mutations. However, given the rarity of noncutaneous melanoma, including acral and mucosal subtypes, the efficacy of BRAF inhibitors for this subset of patients has...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hee Kyung, Lee, Sunyoung, Kim, Kyung, Heo, Mi Hwa, Lee, Hansang, Cho, Jinhyun, Kim, Nayoung K.D., Park, Woongyang, Lee, Su Jin, Kim, Jung Han, Jang, Kee-Taek, Choi, Sang-Hee, Lee, Jeeyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2016
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122709/
https://www.ncbi.nlm.nih.gov/pubmed/27883956
http://dx.doi.org/10.1016/j.tranon.2016.09.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5122709/
https://www.ncbi.nlm.nih.gov/pubmed/27883956
http://dx.doi.org/10.1016/j.tranon.2016.09.004

Ejemplares similares